Diabetes Mellitus Registry Study Using Real World Data from Medical Devices and Clinical Outcomes in Outpatient Care
Led by Ziekenhuisgroep Twente · Updated on 2024-04-19
1500
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting real world data from medical devices and clinical outcomes in patients with diabetes mellitus to better understand the disease and improve care. This observational study focuses on adults with type 1 or type 2 diabetes who attend the outpatient internal medicine clinic at Ziekenhuisgroep Twente. The goal is to build a detailed registry capturing important health information over time.
Participants are followed through routine clinical visits where medical device data and health outcomes are gathered and recorded in the registry. There are no experimental treatments involved, and the study relies on information obtained during standard care visits. The study started in September 2020 and plans to collect data for up to 30 years.
During their participation, patients will have their device data and clinical results regularly collected and monitored. Researchers will evaluate this information to understand patient health trends and outcomes. Participation involves giving informed consent and allowing access to medical records and device data. The study continues until December 2060, with ongoing data collection and review.
CONDITIONS
Brief Title
DIABASE; Diabetes Mellitus Registry in Second Care
Research Team
T
Thomas Urgert, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients visiting the outpatient clinic internal medicine in the ZGT Hospital
Written informed consent
You will not qualify if you...
Severe general diseases or mental disorders making the participation in the study impossible
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 30 years
Participants with diabetes are observed to collect real world data from medical devices and clinical outcomes over time.
Regular visits during outpatient clinic appointments
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
AI-Assisted Smart Family Doctor for Managing Hypertension, Diabetes, and Dyslipidemia in Adults After Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
Randomized Phase I Study Comparing Bioavailability and Safety of SHR-3167 Injection in Healthy Adults Aged 18 to 55
Pilot Study of a Fruit and Vegetable Prescription Program to Improve Diabetes Management in Adults with Type 2 Diabetes
Evaluating a Digital Tool to Help Clinicians Prescribe Personalized Exercise for Adults with Cardiovascular Disease Risk Factors in a Randomized Crossover Trial
Screening for Pancreatic Cancer in Adults Over 50 with New or Worsening Diabetes Using MRI and Blood Tests
Phase I Study of Intraperitoneal Mesothelin-Targeted CAR T-Cell Therapy for Mesothelin-Positive Esophagogastric Adenocarcinoma and Malignant Peritoneal Mesothelioma
Study of Coronary Artery Changes in Adults with Type 2 Diabetes Using CT Angiography
Phase 3 Study of ENERGI-F703 GEL for Treating Diabetic Foot Ulcers
Randomized, Double-Blind, Vehicle-Controlled Parallel Trial
Observational Study of Dapagliflozin for Adults with Type 2 Diabetes and Hypertension
Evaluating Its Safety and Effectiveness
Study of Pharmacokinetics and Safety Comparing Combined Tablet BR3006 With Separate Pills BR3006A, BR3006B, and BR3006C in Healthy Adults Fasting
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
DIABASE: an automatically filled single-centre registry of diabetes mellitus in the Netherlands, combining clinical data with real-world longitudinal wearable device data-a study protocol.
Thomas Urgert, Kilian Derk Rinse Kappert, Anouk Veldhuis...